Back to top

Latest News

Atlas-WebBanner
28 April 2021

New Atlas of MS identifies global gaps in MS clinical management

The MS International Federation has just launched the second part of its update to the Atlas of MS. This 3rd Edition of the Atlas examined clinical management...

autopen injector image
23 April 2021

Ofatumumab (Kesimpta) recommended for PBS subsidy

  • Today, the Pharmaceutical Benefits Advisory Committee(PBAC) has announced their recommendation that ofatumumab be subsidised under the Pharmaceutical Benefit Scheme (PBS).
  • In March 2021 the Therapeutic Good Administration (TGA) approved this medication for the treatment of...
30 March 2021

COVID-19 vaccination program: Phase 1b to include people living with MS

Last reviewed: 27/04/21

The Department of Health has released further details about the Phase 1b roll-out of the COVID-19 vaccination program, including a list of healthcare centres, clinics and GP practices that began administering the COVID-19 vaccine from Monday, 22nd March,...

Older Couple - Aged Care Royal Commission
19 March 2021

MS Australia welcomes release of final Report of the Aged Care Royal Commission

MS Australia welcomes the release of the final Report of the Aged Care Royal Commission. We were very pleased to see that key recommendations in the Report closely align to the...

14 March 2021

TGA approves a new medication for MS: Ofatumumab

  • A new treatment for relapsing MS has been approved by the TGA in Australia
  • Ofatumumab will be marketed under the trade name Kesimpta®
  • This treatment is in the same class as the medication Ocrevus and reduces the number of certain B cells in the body

The...

Zeposia
1 March 2021

Ozanimod (Zeposia®) approved for PBS listing for relapsing remitting MS

Today (1 March, 2021) the Federal Health Minister, the Hon Greg Hunt MP announced the listing of ozanimod (Zeposia®) for the treatment of relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS).

Zeposia was approved for treatment of relapsing forms of MS in Australia by...

18 February 2021

MS Australia and MS Research Australia Facebook Pages Restricted

It is with extreme disappointment that as of 18 February 2021 our MS Australia and MS Research Australia Facebook pages have been shut down, as a result of Facebook’s Australian news restrictions that have now been put in place. Today, Facebook has removed credible news and...
Astrid
1 February 2021

New book 'Growing Up Disabled in Australia' released today!

Edited by writer and appearance advocate, Carly Findlay, 'Growing Up Disabled in Australia' is a rich collection of writing from those negotiating disability in their lives – a group whose voices are not heard often enough:

‘My body and its place in the world seemed...
22 January 2021

$2.9 million in funding awarded to new MS research projects

  • MS Research Australia has awarded $2.9 million in new MS research grants commencing in January 2021.
  • Thanks to the generosity of our supporters in The May 50K, we were able to award grants to all fundable applications in 2020.
  • The 20 new projects target MS Research...
Des Christmas
24 December 2020

Season’s greetings from our Board President

This year has been a tough year for many and the stress and anxiety of living through the pandemic has been particularly difficult for many people living with MS. I know many of you will be glad to see 2020 draw to a close and are feeling optimistic about what 2021 might bring.
 ...
MSIF
10 December 2020

The MS International Federation wants to hear from you!

Submit a story about your support network for #WorldMSDay 2021.
 

MSIF is gathering global stories. We would love to see lots of tales with an Australian flavour/context and which tap into the #MSConnections theme and the 2021 Australian friends & family sub-theme.

Here’...

Pages